Sawicki W, Deptulski T, Janicki S
Department of Pharmaceutical Technology, Medical Academy, Gdańsk, Poland.
Pharmazie. 1989 Apr;44(4):280-1.
The bioavailability of isosorbide dinitrate from an oral therapeutic system (OTS) and from tablet Sorbonit Prolongatum 20,0 mg in 6 volunteers employing a crossover method was studied. Concentrations of isosorbide dinitrate (1),2-mononitrate (2) and 5-mononitrate (3) are plotted as mean concentrations for all volunteers. As evident, the concentration-time curves are similar after administration of both OTS and tablet Sorbonit Prolongatum. Concentration of the nitrates in the serum is close to the maximum level starting 2 h after the drugs were administered. Such concentration is nearly constant for 7 h in the case of nonmetabolized 1 and for 9 h for its metabolites. 24 h after administration metabolites 2 and 3 were found in the serum of 5 subjects. Based on the experimental data, we calculated the areas under curves (AUC). The observed differences in AUC appeared statistically insignificant at the 95% confidence level for the two preparations studied in the case both 1 and its metabolites.
采用交叉法对6名志愿者口服治疗系统(OTS)和索波尼特长效片(Sorbonit Prolongatum)20.0毫克后异山梨醇二硝酸酯的生物利用度进行了研究。绘制了异山梨醇二硝酸酯(1)、2-单硝酸酯(2)和5-单硝酸酯(3)的浓度,作为所有志愿者的平均浓度。显然,服用OTS和索波尼特长效片后浓度-时间曲线相似。给药后2小时血清中硝酸盐浓度接近最高水平。对于未代谢的1,这种浓度在7小时内几乎保持恒定,对于其代谢物则在9小时内几乎保持恒定。给药24小时后,在5名受试者的血清中发现了代谢物2和3。根据实验数据,我们计算了曲线下面积(AUC)。在所研究的两种制剂中,1及其代谢物在95%置信水平下观察到的AUC差异在统计学上不显著。